SavedAdd your journal

Journals / Türk Kardiyoloji Derneği Arşivi / 2020 / Cilt: 48 - Sayı: 1

Ablation of ventricular tachycardia in a patient with a left ventricular assist device

Sol ventrikül destek cihazı olan bir hastadaventriküler taşikardi ablasyonu

Evrim ŞİMŞEK
Emre DEMİR
Sanem NALBANTGİL
Pelin ÖZTÜRK
Emin Evren ÖZCAN
Pages
58–63
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This is a report of ablation of intractable ventricular tachycardia in a patient with a LVAD.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The use of a left ventricular assist device (LVAD) as a bridge to heart transplantation (HTx) or as a destination therapy in patients with a contraindication for HTx is increasing.
📊
Key Findings & Data:However, nearly half of the patients with LVAD support experience a ventricular arrhythmia (VA) in the first year.
💡
Conclusion & Impact:This is a report of ablation of intractable ventricular tachycardia in a patient with a LVAD.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

The use of a left ventricular assist device (LVAD) as a bridge to heart transplantation (HTx) or as a destination therapy in patients with a contraindication for HTx is increasing. However, nearly half of the patients with LVAD support experience a ventricular arrhythmia (VA) in the first year. The history of a pre-LVAD VA is one of the most powerful predictors of VA after LVAD implantation. The clinical experience and data about ablation of a VA in patients with an LVAD are limited. There are important issues to be considered before and during the procedure in LVAD patients compared to other VA ablation patients. This is a report of ablation of intractable ventricular tachycardia in a patient with a LVAD.

Özet

Kalp nakline köprü ya da naklin kontrendike olduğu hastalarda hedef tedavi olarak sol ventrikül destek cihazlarının (SVDC) kullanımı giderek artmaktadır. SVDC desteğialtında ilk bir yıl içinde hastaların yarıya yakını ventriküler aritmi (VA) atağı yaşamaktadır. SVDC öncesi VA olması işlem sonrası süreçteki aritminin en önemli öngördürücüsüdür. SVDC hastalarında VA ablasyonu konusunda klinik tecrübe ve bilgi kısıtlıdır. SVDC hastalarında diğer VA ablasyon hastalarından farklı olarak işlem öncesi ve sırasında dikkatedilmesi gereken basamaklar vardır. Bu yazıda SVDC olan bir hastada inatçı ventriküler taşikardi ataklarının ablasyonu tartışılacaktır.

🔖

Cite This Article

ŞİMŞEK, E., DEMİR, E., NALBANTGİL, S., ÖZTÜRK, P., ÖZCAN, E. E. (2022). Ablation of ventricular tachycardia in a patient with a left ventricular assist device. Türk Kardiyoloji Derneği Arşivi, Cilt: 48 - Sayı: 1, 58–63. https://ajindex.com/articles/631992

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Efimova E, Fischer J, Bertagnolli L, Dinov B, Kircher S, Rolf S, et al. Predictors of ventricular arrhythmia after left ventricular assist device implantation: A large single-center observational study. Heart Rhythm 2017;14:1812–9
  2. Moss JD, Flatley EE, Beaser AD, Shin JH, Nayak HM, Upadhyay GA, et al. Characterization of Ventricular Tachycardia After Left Ventricular Assist Device Implantation as Destination Therapy: A Single-Center Ablation Experience. JACC Clin Electrophysiol 2017;3:1412−24
  3. Kirklin JK, Pagani FD, Kormos RL, Stevenson LW, Blume ED, Myers SL, et al. Eighth annual INTERMACS report: Special focus on framing the impact of adverse events. J Heart Lung Transplant 2017;36:1080−6
  4. Garan AR, Levin AP, Topkara V, Thomas SS, Yuzefpolskaya M, Colombo PC, et al. Early post-operative ventricular arrhythmias in patients with continuous-flow left ventricular assist devices. J Heart Lung Transplant 2015;34:1611−6
  5. Brenyo A, Rao M, Koneru S, Hallinan W, Shah S, Massey HT, et al. Risk of Mortality for Ventricular Arrhythmia in Ambulatory LVAD Patients. J Cardiovasc Electrophysiol 2012;23:515−20
  6. Yoruk A, Sherazi S, Massey HT, Kutyifa V, McNitt S, Hallinan W, et al. Predictors and clinical relevance of ventricular tachyarrhythmias in ambulatory patients with a continuous flow left ventricular assist device. Heart Rhythm 2016;13:1052−6
  7. Simsek E, Nalbantgil S, Demir E, Kemal HS, Mutlu I, Ozturk P, et al. Survival Benefit of Implantable Cardioverter Defibrillator Therapy on Patients with Left Ventricular Assist Device. The Journal of Heart and Lung Transplantation. 2017;36:S180
  8. Drakos SG, Kfoury AG, Hammond EH, Reid BB, Revelo MP, Rasmusson BY, et al. Impact of mechanical unloading on microvasculature and associated central remodeling features of the failing human heart. J Am Coll Cardiol 2010;56:382−91
  9. Harding JD, Piacentino V 3rd, Gaughan JP, Houser SR, Margulies KB. Electrophysiological alterations after mechanical circulatory support in patients with advanced cardiac failure. Circulation 2001;104:1241−7
  10. Sacher F, Reichlin T, Zado ES, Field ME, Viles-Gonzalez JF, Peichl P, et al. Characteristics of ventricular tachycardia ablation in patients with continuous flow left ventricular assist devices. Circ Arrhythm Electrophysiol 2015;8:592−7
  11. Ho G, Braun OÖ, Adler ED, Feld GK, Pretorius VG, Birgersdotter-Green U. Management of Arrhythmias and Cardiac Implantable Electronic Devices in Patients With Left Ventricular Assist De